Logo image of ALTHE.PA

THERACLION (ALTHE.PA) Stock Fundamental Analysis

EPA:ALTHE - Euronext Paris - Matif - FR0010120402 - Common Stock - Currency: EUR

0.57  0 (0%)

Fundamental Rating

1

ALTHE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. ALTHE has a bad profitability rating. Also its financial health evaluation is rather negative. ALTHE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALTHE had negative earnings in the past year.
ALTHE had a negative operating cash flow in the past year.
In the past 5 years ALTHE always reported negative net income.
In the past 5 years ALTHE always reported negative operating cash flow.
ALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

ALTHE's Return On Assets of -50.21% is on the low side compared to the rest of the industry. ALTHE is outperformed by 86.44% of its industry peers.
Industry RankSector Rank
ROA -50.21%
ROE N/A
ROIC N/A
ROA(3y)-35.17%
ROA(5y)-34.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTHE.PA Yearly ROA, ROE, ROICALTHE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M 5M

1.3 Margins

ALTHE's Gross Margin of 42.86% is on the low side compared to the rest of the industry. ALTHE is outperformed by 71.19% of its industry peers.
In the last couple of years the Gross Margin of ALTHE has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALTHE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.68%
GM growth 5Y0.37%
ALTHE.PA Yearly Profit, Operating, Gross MarginsALTHE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

2

2. Health

2.1 Basic Checks

ALTHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALTHE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALTHE has been increased compared to 5 years ago.
Compared to 1 year ago, ALTHE has a worse debt to assets ratio.
ALTHE.PA Yearly Shares OutstandingALTHE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALTHE.PA Yearly Total Debt VS Total AssetsALTHE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.74, we must say that ALTHE is in the distress zone and has some risk of bankruptcy.
ALTHE's Altman-Z score of -0.74 is on the low side compared to the rest of the industry. ALTHE is outperformed by 79.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.74
ROIC/WACCN/A
WACC7.64%
ALTHE.PA Yearly LT Debt VS Equity VS FCFALTHE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M -8M

2.3 Liquidity

ALTHE has a Current Ratio of 2.20. This indicates that ALTHE is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.20, ALTHE is doing good in the industry, outperforming 64.41% of the companies in the same industry.
ALTHE has a Quick Ratio of 1.64. This is a normal value and indicates that ALTHE is financially healthy and should not expect problems in meeting its short term obligations.
ALTHE's Quick ratio of 1.64 is fine compared to the rest of the industry. ALTHE outperforms 71.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.64
ALTHE.PA Yearly Current Assets VS Current LiabilitesALTHE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

ALTHE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.33%.
The Revenue for ALTHE has decreased by -54.44% in the past year. This is quite bad
ALTHE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -21.49% yearly.
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-129.76%
Revenue 1Y (TTM)-54.44%
Revenue growth 3Y-17.55%
Revenue growth 5Y-21.49%
Sales Q2Q%27.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTHE.PA Yearly Revenue VS EstimatesALTHE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTHE.PA Yearly EPS VS EstimatesALTHE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2024 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTHE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTHE.PA Price Earnings VS Forward Price EarningsALTHE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTHE.PA Per share dataALTHE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALTHE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

THERACLION

EPA:ALTHE (8/6/2025, 7:00:00 PM)

0.57

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)09-26 2025-09-26
Inst Owners1.35%
Inst Owner ChangeN/A
Ins Owners19%
Ins Owner ChangeN/A
Market Cap26.41M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 31.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.02
BVpS0
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.86%
FCFM N/A
ROA(3y)-35.17%
ROA(5y)-34.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.68%
GM growth 5Y0.37%
F-Score1
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.38%
Cap/Sales 12.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 1.64
Altman-Z -0.74
F-Score1
WACC7.64%
ROIC/WACCN/A
Cap/Depr(3y)103.96%
Cap/Depr(5y)101.1%
Cap/Sales(3y)14.86%
Cap/Sales(5y)14.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-129.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.44%
Revenue growth 3Y-17.55%
Revenue growth 5Y-21.49%
Sales Q2Q%27.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-116.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.16%
OCF growth 3YN/A
OCF growth 5YN/A